Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Fibromyalgia · Primary Fibromyalgia · TNXP

Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals Holding trial registry — 36 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
200 Connell Dr, Berkeley Heights, New Jersey 07922, US HQ
2007 Founded
154 Employees
Public company Type
TNXP · NYSE Ticker
Company details
Status
Public
HQ
200 Connell Dr, Berkeley Heights, New Jersey 07922, US
Founded
2007
Employees
154
Programs
30
Drugs
10
Patents
86
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

Tonix Pharmaceuticals Holding clinical trials

Registry index of 36 ClinicalTrials.gov studies linked to Tonix Pharmaceuticals Holding programs — each row shows trial ID, program name, phase, status, and indication.

Tonix Pharmaceuticals Holding trial registry — 36 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Tonix Pharmaceuticals Holding.

  1. 2017-004466-98 — Phase 1

    Clinical update

  2. Intranasal Oxytocin (IN-OXT) — Phase 1

    Clinical update

  3. Cyclobenzaprine HCl — Phase 2

    Clinical update

  4. Treatment A — Phase 1

    Clinical update

  5. Treatment A — Phase 1

    Clinical update

  6. TNX-2110 — Phase 1

    Clinical update

  7. TNX-102 SL Tablets at 2.8 mg — Phase 1

    Clinical update

  8. TNX-102 SL Tablet — Phase 1

    Clinical update

Trial registry

36 studies
  25. NCT05216510

    TNX-2110

    Phase 1 terminated mab

    Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2

    CT.gov ↗

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.